Healthpeak Q4 2024 Earnings Report
Key Takeaways
Healthpeak Properties reported fourth-quarter results with a net income of $0.01 per share, Nareit FFO of $0.44 per share, FFO as Adjusted of $0.46 per share, and AFFO of $0.40 per share. Total Same-Store Portfolio Cash (Adjusted) NOI growth was 5.4%. The company's Board of Directors declared a 1.7% increase in the quarterly common stock cash dividend to $0.305 per share.
Net income of $0.01 per share, Nareit FFO of $0.44 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.40 per share, and Total Same-Store Portfolio Cash (Adjusted) NOI growth of 5.4%.
Healthpeak's Board of Directors declared a 1.7% increase in the Company's quarterly common stock cash dividend to $0.305 per share.
Fourth quarter new and renewal lease executions totaled 1.5 million square feet.
Originated loans and other investments totaling up to approximately $126 million during the fourth quarter 2024 and through January 2025.
Healthpeak
Healthpeak
Forward Guidance
For full year 2025, Diluted earnings per common share of $0.30 – $0.36, Diluted Nareit FFO per share of $1.81 – $1.87, Diluted FFO as Adjusted per share of $1.81 – $1.87 and Total Merger-Combined Same-Store Cash (Adjusted) NOI growth from 3.0% – 4.0%
Positive Outlook
- Diluted earnings per common share of $0.30 – $0.36
- Diluted Nareit FFO per share of $1.81 – $1.87
- Diluted FFO as Adjusted per share of $1.81 – $1.87
- Total Merger-Combined Same-Store Cash (Adjusted) NOI growth from 3.0% – 4.0%